Creative Biolabs has announced the expansion of its advanced single-cell multi-omics and RNA sequencing solutions, aiming to support biomedical discovery by providing researchers with high-resolution cellular profiling tools. The upgraded suite offers end-to-end services ranging from single-cell transcriptome profiling to integrated multimodal and multi-omics workflows, according to a company press release.
As life science research increasingly moves from bulk tissue profiling to single-cell resolution, dissecting cellular heterogeneity has become essential for identifying rare cell subpopulations, characterizing complex tumor microenvironments, and tracing cell lineage trajectories. To meet these needs, Creative Biolabs delivers robust, high-throughput single-cell RNA sequencing services that offer high sensitivity and coverage across thousands of individual cells, providing high-resolution transcriptomic insights from diverse fresh biological specimens.
The platform also features specialized single-nucleus RNA sequencing (snRNA-seq) capabilities to address the long-standing laboratory challenge of processing complex, fibrous, or biobanked archival samples. For tissues where single-cell dissociation is prone to cell damage, dissociation-induced stress responses, or selective loss of fragile cell types—such as human brain, myocardium, or flash-frozen clinical biopsies—Creative Biolabs provides an optimized single-cell nuclei RNA sequencing service. By isolating intact nuclei, this approach bypasses harsh enzymatic dissociation while minimizing dissociation-related artifacts and retaining informative nuclear RNA profiles, dramatically expanding the scope of clinical translational research.
Recognizing that cellular identity is orchestrated across multiple regulatory layers, Creative Biolabs goes beyond single-dimensional analysis by advancing its high-throughput single-cell multi-omics service. This integrated platform allows the simultaneous interrogation of genomic variations, epigenomic landscapes (e.g., chromatin accessibility), cell surface proteomics (CITE-seq), and transcriptomes within identical single cells. By directly linking epigenetic regulation and genomic alterations to gene expression readouts, the service enables researchers to construct multi-dimensional cellular atlases and uncover novel therapeutic targets with unprecedented biological clarity.
"Understanding biology at single-cell and single-nucleus resolution is no longer a luxury—it is fundamental to precision medicine and biomarker discovery," said a senior scientist at Creative Biolabs. "Our goal is to provide researchers with a seamless, modular analytical ecosystem that transforms difficult biological samples into reliable, high-dimensional datasets with rigorous bioinformatics support."
Supported by advanced microfluidics technologies, stringent quality control benchmarks, and tailored bioinformatics pipelines, Creative Biolabs continues to partner with academic and biopharmaceutical research teams worldwide to unravel the complexities of human disease.
The implications of this expansion are significant for the biomedical research community. By offering integrated single-cell and single-nucleus solutions, Creative Biolabs addresses a critical bottleneck in translational research: the ability to analyze challenging clinical samples that were previously difficult to process. This could accelerate discoveries in oncology, where understanding tumor heterogeneity is key to developing targeted therapies; in immunology, where immune cell profiling can reveal mechanisms of response and resistance; and in neuroscience, where single-nucleus RNA sequencing of brain tissue can provide insights into neurological disorders. Furthermore, the multi-omics platform enables a more comprehensive view of cellular regulation, potentially leading to the identification of novel biomarkers and drug targets. As precision medicine continues to evolve, access to such high-resolution analytical tools will be essential for researchers aiming to translate basic science into clinical applications.
For more information about Creative Biolabs and its full suite of single-cell analytical solutions, visit https://singlecell.creative-biolabs.com/.
